Engineering T lymphocytes for the robust treatment of cervical cancer (IMAGE)

Juntendo University Research Promotion Center

Engineering T lymphocytes for the robust treatment of cervical cancer

Caption

Through strategic gene-editing, researchers have overcome one of the main roadblocks of iPSC-derived rejuvenated T lymphocytes in cervical cancer therapy.

Credit

Dr. Miki Ando from Juntendo University

Usage Restrictions

You are free to share and adapt the Infographic material, but attribution is required, with a link to the news source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.